![Robert Durgé](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Robert Dugré is President and Chief Executive Officer of AngioChem, Inc. He was a Co-Founder of ID Biomedical Corporation.
He was Vice President of Business Development for BioChem Vaccines, Inc., Biochem Pharma, Inc. and Shire Biologics.
He received a PhD from the University of Quebec in 1978.
Anciens postes connus de Robert Durgé
Sociétés | Poste | Fin |
---|---|---|
Angiochem, Inc.
![]() Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | President | - |
Formation de Robert Durgé
University of Quebec | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Angiochem, Inc.
![]() Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |